AzTrials
AzTrials

Postprandial PeriodNCT03572296

Effect of Drinks Containing Fruit Polyphenol Extracts and Fibre on Postprandial Glycaemia. (Glu-MIX)

A study testing Polyphenol and fibre and Fibre in people with Postprandial Period, run by Lucozade Ribena Suntory at 1 site in United Kingdom.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Postprandial glycaemia refers to the transient rise in blood glucose levels that occurs after consuming a meal. Large fluctuations in blood glucose levels, experienced on a frequent basis, may impair the functioning of pancreatic beta cells, and thus elevate the risk of developing type 2 diabetes mellitus (T2DM) and… Read more about this study

Who is it for?
Ages 18 to 70 yearsHealthy volunteers can take part
Conditions the study is for
Postprandial Period
What is being tested?
Polyphenol and fibre and Fibre
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
38 participants
Where
1 siteUnited Kingdom
Study dates
25 Jun 2018to 28 Jan 2019
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Age: 18-70 years
  • Men and women
  • Healthy (free of diagnosed diseases listed in the exclusion criteria)
  • Body Mass Index 18-35 kg/m2
  • Able to understand the information sheet and willing to comply with study protocol
  • Able to give informed written consent

Who cannot join

  • Those diagnosed with Phenylketonuria (PKU)
  • Those with known or suspected food intolerances, allergies or hypersensitivity
  • Women who are known to be pregnant or who are intending to become pregnant over the course of the study
  • Women who are breastfeeding
  • Participation in another clinical trial
  • Those who have donated blood within 3 months of the screening visit and participants for whom participation in this study would result in having donated more than 1500 millilitres of blood in the previous 12 months.
Show all 16Show fewer
  • Full Blood Counts and Liver Function test results outside of the normal range.
  • Current smokers, or reported giving up smoking within the last 6 months
  • History of substance abuse or alcoholism
  • Reported history of Cardiovascular disease, diabetes (or fasting glucose ≥ 7.1 mmol/L), cancer, kidney, liver or bowel disease, gastrointestinal disorder or use of drug likely to alter gastrointestinal function
  • Unwilling to restrict consumption of specified high polyphenol/ high fibre foods for 48 h before the study
  • Weight change >3 kg in preceding 2 months
  • Blood pressure ≥160/100 mmHg
  • Total cholesterol ≥ 7.5 mmol/L; fasting triacylglycerol concentrations ≥ 5.0 mmol/L
  • Medications that may interfere with the study: alpha-glucosidase inhibitors (acarbose: Glucobay), insulin sensitizing drugs (metformin: Glucophage, Glucophage SR, Eucreas, Janumet; thiazolidinediones: Actos, Competact), sulfonylureas (Daonil, Diamicron, Diamicron MR, Glibenese, Minodiab, Amaryl Tolbutamide), and lipid lowering drugs (statins, nicotinic acid, colestyramine anhydrous, ezetimibe, fibrates). Other medications should be reviewed by medical representative from KCL on a case by case basis.
  • Nutritional supplements that may interfere with the study: higher dose vitamins/minerals (>200% Recommend Nutrient Intake), B vitamins, Vitamin C, calcium, copper, chromium, iodine, iron, magnesium, manganese, phosphorus, potassium and zinc. Subjects already taking vitamin or minerals at a dose around 100% or less up to 200% of the RNI, or evening primrose/algal/fish oil supplements will be asked to maintain habitual intake patterns, ensuring that they take them every day and not sporadically. They will be advised not to stop taking supplements or start taking new supplements during the course of the study.

Trial locations and contacts

1 site in 1 country.

United Kingdom1 site
  • Metabolic Research Unit

    London, SE1 9NH

Other trials in United Kingdom

About this study

Official title: Effect of Drinks Containing Fruit Polyphenol Extracts and Fibre on Postprandial Glycaemia. The Glu-MIX Study

Postprandial glycaemia refers to the transient rise in blood glucose levels that occurs after consuming a meal. Large fluctuations in blood glucose levels, experienced on a frequent basis, may impair the functioning of pancreatic beta cells, and thus elevate the risk of developing type 2 diabetes mellitus (T2DM) and cardiovascular disease. Our group has previously shown that consuming a drink containing fruit polyphenols immediately before a meal, may reduce postprandial glycaemia. Importantly, other fruit components, namely soluble fibres, also impact on carbohydrate digestion by slowing gastric emptying rates. Combining fruit polyphenols and fibre in a drink may, potentially, have additive or synergistic effects on reducing postprandial glycaemia.

This study will investigate the effects of drinks containing blackcurrant polyphenol extract combined with pulp (source of fibre), and pulp alone, on postprandial outcomes and cognitive function following a mixed carbohydrate (starch and sucrose) test meal.

Read the detailed description

Intake of carbohydrate-rich foods transiently increases blood glucose levels (known as postprandial glycaemia). Repeated, high, postprandial glucose responses are evidenced to impair pancreatic beta cell function, thus increasing the risk of developing type-2 diabetes mellitus and cardiovascular disease. Therefore, meals that elicit a reduced, or more gradual, rise in blood glucose levels are desirable.

Previous studies have shown that consuming a drink containing fruit polyphenols, such as those from blackcurrants (BC), immediately before a high carbohydrate meal, reduced the postprandial glycaemic response. Importantly, other fruit components, namely soluble fibres, also impact on carbohydrate digestion by slowing gastric emptying rates. It is not yet known the effect of combining fibre and polyphenols on postprandial glycaemia. Although limited, there is a growing body of evidence showing beneficial acute effects of polyphenols in cognitive function which is of great interest in many work and academic environments where fast cognitive enhancement is wanted to perform a task or an exam.

This study will investigate the effects of drinks containing BC polyphenol extract combined with pulp (source of fibre), and pulp alone, on postprandial outcomes and cognitive function following a mixed carbohydrate (starch and sucrose) test meal.

Study design: A randomised, controlled, double-blind, cross-over study, of the healthy adult UK population, will be conducted. All subjects will receive the placebo drink, pulp only drink and the pulp with polyphenol drink in a random order. Baseline (fasted) blood samples will be taken before consuming the test drink (T0 min). Immediately following consumption of the drink, a mixed carbohydrate test meal will be consumed. Further blood samples will be collected at regular times until T150 min. Blood samples will be analysed for plasma glucose, insulin, glucose-dependent insulinotropic peptide (GIP) and C-peptide. Subjects will also perform a 30 min computer based cognitive performance test at baseline (T-45 min) and endpoint (T165 min). Visual analogue scales will be used to assess the effect of the test drinks on a range of sensory characteristics e.g. palatability, satiety and subjective mood feelings. Finally, an ad libitum pasta meal at the end of the study visit (T 215 min) will be used to assess the effects on energy intake.

Being tested
Placebo, Polyphenol and fibre, Fibre
Keywords
Blackcurrant, Polyphenols, Pulp, Fibre, Glucose, Postprandial, Metabolism, Cognition

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • PlaceboDietary supplement

    Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.

  • Polyphenol and fibreDietary supplement

    Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.

  • FibreDietary supplement

    Drinks will be delivered in random order at 3 separate study visits immediately before a high carbohydrate meal. A minimum of 4 days (ideally 7 days) wash-out period will be required between study days.

Study groups in NCT03572296
Study groupRoleWhat they receive
PlaceboPlacebo comparatorNo polyphenols or fibre will be delivered in a low sugar drink.
Receives: Dietary Supplement: Placebo
Polyphenol and fibreExperimentalBlackcurrant extract (800 mg total polyphenols) and pulp (source of fibre) will be delivered in a low sugar drink.
Receives: Dietary Supplement: Polyphenol and fibre
FibreExperimentalPulp (source of fibre) will be delivered in a low sugar drink.
Receives: Dietary Supplement: Fibre

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Postprandial glycaemia (iAUC 0-30 min)

    The primary endpoint is iAUC 0-30 min for plasma glucose concentrations

    Measured: 30 min

Secondary outcomes (24)
  1. Postprandial glycaemia: iAUC 0-120 min

    iAUC 0-120 min for plasma glucose concentrations

    Measured: 120 min

  2. Postprandial glycaemia: iAUC 0-150 min

    iAUC 0-150 min for plasma glucose concentrations

    Measured: 150 min

  3. Postprandial glycaemia: iCmax

    iCmax for plasma glucose concentrations

    Measured: 150 min

  4. Postprandial glycaemia: Tmax

    Tmax for plasma glucose concentrations

    Measured: 150 min

  5. Postprandial glycaemia: absolute concentrations at specific time points

    Absolute concentrations at specific time points, for plasma glucose concentrations

    Measured: 150 min

  6. Postprandial insulinemia: iAUC 0-30 min

    iAUC 0-30 min for serum insulin concentrations

    Measured: 30 min

  7. Postprandial insulinemia: iAUC 0-120 min

    iAUC 0-120 min for serum insulin concentrations

    Measured: 120 min

  8. Postprandial insulinemia: iAUC 0-150 min

    iAUC 0-150 min for serum insulin concentrations

    Measured: 150 min

  9. Postprandial insulinemia: iCmax

    iCmax, for serum insulin concentrations

    Measured: 150 min

  10. Postprandial insulinemia: Tmax

    Tmax for serum insulin concentrations

    Measured: 150 min

  11. Postprandial insulinemia: absolute concentrations at specific time points

    Absolute concentrations at specific time points, for serum insulin concentrations

    Measured: 150 min

  12. Postprandial C-peptide: iAUC 0-30 min

    iAUC 0-30 min for plasma C-peptide concentrations

    Measured: 30 min

  13. Postprandial C-peptide: iAUC 0-120 min

    iAUC 0-120 min for plasma C-peptide concentrations

    Measured: 120 min

  14. Postprandial C-peptide: iAUC 0-150 min

    iAUC 0-150 min for plasma C-peptide concentrations

    Measured: 150 min

  15. Postprandial C-peptide: iCmax

    iCmax for plasma C-peptide concentrations

    Measured: 150 min

  16. Postprandial C-peptide: Tmax

    Tmax for plasma C-peptide concentrations

    Measured: 150 min

  17. Postprandial C-peptide: Absolute concentrations at specific time points

    Absolute concentrations at specific time points, for plasma C-peptide concentrations

    Measured: 150 min

  18. Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-30 min

    iAUC 0-30 min for plasma GIP concentrations

    Measured: 30 min

  19. Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-120 min

    iAUC 0-120 min for plasma GIP concentrations

    Measured: 120 min

  20. Postprandial blood glucose-dependent insulinotropic peptide (GIP): iAUC 0-150 min

    iAUC 0-150 min for plasma GIP concentrations

    Measured: 150 min

  21. Postprandial blood glucose-dependent insulinotropic peptide (GIP): iCmax

    iCmax, for plasma GIP concentrations

    Measured: 150 min

  22. Postprandial blood glucose-dependent insulinotropic peptide (GIP): Tmax

    Tmax for plasma GIP concentrations

    Measured: 150 min

  23. Postprandial blood glucose-dependent insulinotropic peptide (GIP): Absolute concentrations at specific time points

    Absolute concentrations at specific time points, for plasma GIP concentrations

    Measured: 150 min

  24. Cognitive function test scores

    Descriptive statistics

    Measured: Before and after 150 min blood collection

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Jun 2018
  2. Study start25 Jun 2018
  3. Primary completion28 Jan 2019
  4. Study completion28 Jan 2019

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Model description
Cross-over design. Each participant receives placebo plus 2 treatments.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
38 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03572296
Sponsor's protocol ID
HVS-010
Status last verified
Jan 2019
First submitted
19 Jun 2018
Last updated
31 Jan 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Castro-Acosta ML, Smith L, Miller RJ, McCarthy DI, Farrimond JA, Hall WL. Drinks containing anthocyanin-rich blackcurrant extract decrease postprandial blood glucose, insulin and incretin concentrations. J Nutr Biochem. 2016 Dec;38:154-161. doi: 10.1016/j.jnutbio.2016.09.002. Epub 2016 Sep 14.

    PubMed 27764725
  • Pinto AM, Hobden MR, Brown KD, Farrimond J, Targett D, Corpe CP, Ellis PR, Todorova Y, Socha K, Bahsoon S, Haworth C, Marcel M, Nie X, Hall WL. Acute effects of drinks containing blackcurrant and citrus (poly)phenols and dietary fibre on postprandial glycaemia, gut hormones, cognitive function and appetite in healthy adults: two randomised controlled trials. Food Funct. 2023 Nov 13;14(22):10163-10176. doi: 10.1039/d3fo03085g.

    PubMed 37902089

Questions about this trial

What is this clinical trial studying?

A study testing Polyphenol and fibre and Fibre in people with Postprandial Period, run by Lucozade Ribena Suntory at 1 site in United Kingdom.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 16 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 31 Jan 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Postprandial glycaemia (iAUC 0-30 min) (time frame: 30 min). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03572296, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 31 Jan 2019.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in